Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality
- 5 April 2007
- journal article
- research article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 21 (3) , 327-333
Abstract
Recent studies highlight the contribution of antiplatelet therapy to clinical severity and increased mortality of intracerebral hemorrhage (ICH) but results are discrepant. The aim of this report was to evaluate the association between antiplatelet drug use preceding the onset of ICH and the mortality, assessed at regular intervals, among patients with acute ICH. We analyzed data from a randomized study which enrolled consecutive patients with a documented acute ICH to evaluate the efficacy of intermittent pneumatic compression of the legs in venous thrombosis prevention. Clinical characteristics and treatment used before the onset of ICH were checked at the time of inclusion. Mortality was assessed at regular intervals until 3 months after ICH diagnosis. Among 138 patients included in this report, 30 were current users of antiplatelet therapy at the time of ICH; they were significantly older and less frequently heavy drinkers than non‐users of antiplatelet drugs. Mortality rates were 20% at 8 days, 40% at 1 month, and 47% at 3 months among antiplatelet drug users compared with 6.5%, 13% and 19% among non‐users. The corresponding estimated risks for mortality related to antiplatelet drug use were 3.6 (95% CI 1.1–12), 4.5 (95% CI 1.8–11), and 3.6 (95% CI 1.5–8.6). Adjusted for age, hypertension and alcohol over use, antiplatelet therapy remained significantly associated with an increased mortality rate of acute ICH. Current antiplatelet drug use preceding the onset of ICH is associated with increased short‐term ICH mortality, independently of age.Keywords
This publication has 16 references indexed in Scilit:
- Pretreatment With Antiplatelet Agents Is Not Independently Associated With Unfavorable Outcome in Intracerebral HemorrhageStroke, 2006
- Regular Aspirin-Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for DeathStroke, 2006
- Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhageNeurology, 2005
- Prevention of venous thrombosis in patients with acute intracerebral hemorrhageNeurology, 2005
- Recombinant Activated Factor VII for Acute Intracerebral HemorrhageNew England Journal of Medicine, 2005
- Prophylactic Treatment with Desmopressin Does Not Reduce Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Before SurgeryAnesthesia & Analgesia, 2004
- Indications for Early Aspirin Use in Acute Ischemic StrokeStroke, 2000
- A Prospective Community-Based Study of Stroke in Germany—The Erlangen Stroke Project (ESPro)Stroke, 1998
- Comparable Studies of the Incidence of Stroke and its Pathological TypesStroke, 1997
- Pharmacological prophylaxis of bleeding in surgical patients treated with aspirinEuropean Journal of Anaesthesiology, 1997